{'fraction_non_alphanumeric': 0.01921537229783827, 'fraction_numerical': 0.016012810248198558, 'mean_word_length': 5.906077348066298, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Adverse Drug Reaction of Medroxyprogesterone Acetate Injectable Contraceptive on Acceptor Family Planning Programme

The government's family planning strategy for population balance is using contraception for couples of reproductive age. According to the 2018 Basic Health Research, the most common contraceptive is medroxyprogesterone acetate depot injection. The acceptor may experience complaints as a result of using these contraceptives. This study aims to determine the side effects of using depot medroxyprogesterone acetate injectable contraceptives on family planning acceptors in Jungai village, Rambang Kapak Tengah district, Prabumulih city in 2020. This study used a cross-sectional design, with data collected by interviews and a validated questionnaire. Purposive sampling was used to select 97 respondents who met the inclusion criteria. Univariate analysis was used to examine data from interviews. The percentage of adverse events experienced by acceptors of depot medroxyprogesterone acetate injectable contraceptive was 80% emotional changes, 75% menstrual disorders, 66% headaches, 66% weight changes, and 40% bone pain. Health professionals can use the findings of this study to provide counseling to family planning acceptors.